Study of Probiotic supplements to reduce insulin resistance in gestational diabetes mellitus

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

TCTR

Registry ID

TCTR20170606002

Enrollment

Registered

2017-06-06

Start date

2017-01-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Side effects from probiotics &#45

Interventions

Live Bifidobacterium 1000M and Lactobacillus 1000M ,Gelatin&#45

containing capsules

Active Comparator Dietary Supplement,Placebo Comparator Dietary Supplement

Probiotic supplements&#44

infloran,Placebo&#44

gelatin comtaining capsule

Eligibility

Sex/Gender

Female

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Singleton pregnancy Age > 18 years old No chronic disease no probiotic supplements or probiotic foods used before study no fetal anomaly Patients agree to participate in the research

Exclusion criteria

Exclusion criteria: Use antibiotics during research There are side effects of probiotic drug use Other treatments(insulin)

Design outcomes

Primary

Measure	Time frame
HOMA-IR, fasting blood sugar, fasting insulin level weeks 0 and 4 after at least 12h of fasting blood samples	—

Secondary

Measure	Time frame
Maternal weight gain, pregnancy outcome 4 weeks after intervention, at delivery scales	—

Countries

Thailand

Contacts

Public ContactAthasit Kijmanawat

Ramathibodi hospital

athasit_7@hotmail.com0896437121

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026